Previous close | 1.4200 |
Open | 1.4500 |
Bid | 1.4800 x 400 |
Ask | 1.5100 x 600 |
Day's range | 1.4305 - 1.5100 |
52-week range | 1.0400 - 5.8500 |
Volume | |
Avg. volume | 7,021,072 |
Market cap | 116.879M |
Beta (5Y monthly) | 1.06 |
PE ratio (TTM) | 7.14 |
EPS (TTM) | 0.2100 |
Earnings date | 06 Aug 2024 - 12 Aug 2024 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | 5.32 |
We recently compiled a list of the 10 Best One-Dollar Stocks To Buy Now. In this article, we are going to take a look at where CytomX Therapeutics, Inc. (NASDAQ:CTMX) stands against the other one-dollar stocks. The upward trend in the stock market has resumed, supported by strong first-quarter and second-quarter results that have relieved […]
Key Insights Institutions' substantial holdings in CytomX Therapeutics implies that they have significant influence...
SOUTH SAN FRANCISCO, Calif., June 18, 2024 (GLOBE NEWSWIRE) -- CytomX Therapeutics, Inc. (Nasdaq: CTMX), a leader in the field of masked, conditionally activated biologic therapeutics, today announced that Sean McCarthy, D.Phil., chief executive officer and chairman, will participate in a fireside chat at the H.C. Wainwright 2nd Annual Immune Cell Engager Virtual Conference on Tuesday, June 25, 2024, at 2:00 p.m. ET. A live webcast of the presentation will be available on the Events and Presenta